Section Arrow
Quote
ARCT.NASDAQ
- Arcturus Therapeutics Holdings
Quotes are at least 15-min delayed:2024/05/16 14:13 EDT
Last
 30.7
+1.685 (+5.81%)
Day High 
30.99 
Prev. Close
29.015 
1-M High
30.89 
Volume 
176.16K 
Bid
30.65
Ask
30.77
Day Low
28.86 
Open
29.27 
1-M Low
25.41 
Market Cap 
781.43M 
Currency USD 
P/E 7.2 
%Yield 1.39 
10-SMA 27.74 
20-SMA 27.23 
50-SMA 30.98 
52-W High 43.81 
52-W Low 17.52 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.03/0.61
Enterprise Value
807.33M
Balance Sheet
Book Value Per Share
9.80
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
157.75M
Operating Revenue Per Share
9.75
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
SCPXScorpius Holdings0.0994+0.0217+27.93%-- 
NBYNovaBay Pharmaceuticals0.1115+0.007+6.70%-- 
DNAGinkgo Bioworks Holdings0.8298-0.0093-1.11%-- 
JAGXJaguar Health0.2786+0.0235+9.21%-- 
NVAXNovavax14.1499+1.2499+9.69%-- 
Quotes are at least 15-min delayed：2024/05/16 14:13 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.